Trial Profile
Phase I trial of DSP-3748 for the treatment of cognitive impairment associated with schizophrenia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs DSP 3748 (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 02 Nov 2015 New trial record